Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells

Acta Biomaterialia

Volumn 23, Issue , 2015, Pages 147-156

  Zhao, Qinfu ^a   Liu, Jia ^a   Zhu, Wenquan ^b   Sun, Changshan ^a   Di, Donghua ^a   Zhang, Ying ^a   Wang, Pu ^c   Wang, Zhanyou ^c   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c NORTHEASTERN UNIVERSITY   (China)

Author keywords

Disulfide bonds; Doxorubicin; Dual stimuli responsive; Hyaluronic acid; Mesoporous silica nanoparticles

Indexed keywords

BIOCOMPATIBILITY; CARDIOVASCULAR SYSTEM; CONTROLLED DRUG DELIVERY; COVALENT BONDS; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE; FUNCTIONAL MATERIALS; HYALURONIC ACID; LANTHANUM COMPOUNDS; MESOPOROUS MATERIALS; MICELLES; MOLECULAR BIOLOGY; ORGANIC ACIDS; SILICA NANOPARTICLES; SULFUR COMPOUNDS; SURFACE CHEMISTRY;

CANCER CELLS; CELLULAR UPTAKE; DISULPHIDE BONDS; DOXORUBICIN; DUAL-STIMULUS RESPONSIVE; MESOPOROUS SILICA NANOPARTICLES; MESOPOROUS SILICAS; STIMULI-RESPONSIVE; STIMULI-RESPONSIVE DELIVERIES; TARGETED DELIVERY;

TARGETED DRUG DELIVERY;

DOXORUBICIN; GLUTATHIONE; HERMES ANTIGEN; HYALURONIC ACID; MESOPOROUS SILICA NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; DELAYED RELEASE FORMULATION; NANOCAPSULE; NANOCONJUGATE; SILICON DIOXIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CIRCULATION TIME; CONJUGATION; CONTROLLED DRUG RELEASE; DISULFIDE BOND; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DUAL STIMULI RESPONSIVE DELIVERY SYSTEM; ENDOCYTOSIS; FLUORESCENCE; HYDRODYNAMICS; HYDROLYSIS; IN VITRO STUDY; LIGHT SCATTERING; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; PRIORITY JOURNAL; STATIC ELECTRICITY; STEREOSPECIFICITY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG EFFECTS; HUMAN; METABOLISM; MOUSE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; PH; POROSITY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOXORUBICIN; HUMANS; HYALURONIC ACID; HYDROGEN-ION CONCENTRATION; MICE; NANOCAPSULES; NANOCONJUGATES; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; POROSITY; SILICON DIOXIDE;

EID: 84938215225     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.05.010     Document Type: Article

References (29)

1. T.-W. Kim, I.I. Slowing, P.-W. Chung, and V.S.-Y. Lin Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules ACS Nano 5 2010 360 366
2. C.H. Lee, S.H. Cheng, I. Huang, J.S. Souris, C.S. Yang, C.Y. Mou, and et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics Angew Chem 122 2010 8390 8395
3. W. Chen, P. Zhong, F. Meng, R. Cheng, C. Deng, J. Feijen, and et al. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release J Control Release 167 2013 171 179
4. X. Wang, X. Cai, J. Hu, N. Shao, F. Wang, Q. Zhang, and et al. Glutathione-triggered "Off-On" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles J Am Chem Soc 135 2013 9805 9810
5. R. Guo, L.L. Li, W.H. Zhao, Y.X. Chen, X.Z. Wang, C.J. Fang, and et al. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent Nanoscale 4 2012 3577 3583
6. C. Park, H. Kim, S. Kim, and C. Kim Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests J Am Chem Soc 131 2009 16614 16615
7. D. He, X. He, K. Wang, J. Cao, and Y. Zhao A light-responsive reversible molecule-gated system using thymine-modified mesoporous silica nanoparticles Langmuir 28 2012 4003 4008
8. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J Control Release 152 2011 2 12
9. Y. Cui, H. Dong, X. Cai, D. Wang, and Y. Li Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release ACS Appl Mater Interfaces 4 2012 3177 3183
10. G. Saito, J.A. Swanson, and K.-D. Lee Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv Drug Deliv Rev 55 2003 199 215
11. R. Cheng, F. Meng, C. Deng, H.-A. Klok, and Z. Zhong Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery Biomaterials 34 2013 3647 3657
12. C. Chen, J. Geng, F. Pu, X. Yang, J. Ren, and X. Qu Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery Angew Chem Int Ed 50 2011 882 886
13. Y. Zhao, J.L. Vivero-Escoto, I.I. Slowing, B.G. Trewyn, and V.S. Lin Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery Expert Opin Drug Deliv 7 2010 1013 1029
14. R. Stern, and M.J. Jedrzejas Hyaluronidases: their genomics, structures, and mechanisms of action Chem Rev 106 2006 818 839
15. B.P. Toole Hyaluronan: from extracellular glue to pericellular cue Nat Rev Cancer 4 2004 528 539
16. K.Y. Choi, H.Y. Yoon, J.-H. Kim, S.M. Bae, R.-W. Park, Y.M. Kang, and et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy ACS Nano 5 2011 8591 8599
17. K.L. Chao, L. Muthukumar, and O. Herzberg Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis Biochemistry 46 2007 6911 6920
18. C. Surace, S. Arpicco, Dufaÿ.-Wojcicki. Al, Marsaud. Vr, Bouclier. Cl, D. Clay, and et al. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells Mol Pharm 6 2009 1062 1073
19. I. Rivkin, K. Cohen, J. Koffler, D. Melikhov, D. Peer, and R. Margalit Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors Biomaterials 31 2010 7106 7114
20. H.-J. Cho, H.Y. Yoon, H. Koo, S.-H. Ko, J.-S. Shim, J.-H. Lee, and et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel Biomaterials 32 2011 7181 7190
21. Z. Chen, Z. Li, Y. Lin, M. Yin, J. Ren, and X. Qu Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery Chem-Eur J 19 2013 1778 1783
22. Y.W. Ebright, Y. Chen, Y. Kim, and R.H. Ebright S-[2-(4-A zidosalicylamido) ethylthio]-2-thiopyridine: radioiodinatable, cleavable, photoactivatible cross-linking agent Bioconjugate Chem 7 1996 380 384
23. M. Yu, S. Jambhrunkar, P. Thorn, J. Chen, W. Gu, and C. Yu Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells Nanoscale 5 2013 178 183
24. T. Ukmar, A. Godec, O. Planinšek, V. Kaučič, G. Mali, and M. Gaberšček The phase (trans) formation and physical state of a model drug in mesoscopic confinement Phys Chem Chem Phys 13 2011 16046 16054
25. H. Tang, J. Guo, Y. Sun, B. Chang, Q. Ren, and W. Yang Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery Int J Pharm 421 2011 388 396
26. T. Ukmar, U. Maver, O. Planinšek, V. Kaučič, M. Gaberšček, and A. Godec Understanding controlled drug release from mesoporous silicates: theory and experiment J Control Release 155 2011 409 417
27. T. Ukmar, M. Gaberšček, F. Merzel, and A. Godec Modus operandi of controlled release from mesoporous matrices: a theoretical perspective Phys Chem Chem Phys 13 2011 15311 15317
28. L.-S. Wang, L.-C. Wu, S.-Y. Lu, L.-L. Chang, I.-T. Teng, C.-M. Yang, and et al. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding ACS Nano 4 2010 4371 4379
29. Q. Zhao, H. Geng, Y. Wang, Y. Gao, J. Huang, Y. Wang, and et al. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery ACS Appl Mater Interfaces 6 2014 20290 20299